Revvity (RVTY) Stock Forecast, Price Target & Predictions
RVTY Stock Forecast
Revvity stock forecast is as follows: an average price target of $127.86 (represents a 13.59% upside from RVTY’s last price of $112.56) and a rating consensus of 'Buy', based on 9 wall street analysts offering a 1-year stock forecast.
RVTY Price Target
The average price target for Revvity (RVTY) is $127.86 based on 1-year price targets from 9 Wall Street analysts in the past 3 months, with a price target range of $140.00 to $110.00. This represents a potential 13.59% upside from RVTY's last price of $112.56.
RVTY Analyst Ratings
According to 9 Wall Street analysts, Revvity's rating consensus is 'Buy'. The analyst rating breakdown for RVTY stock is 0 'Strong Buy' (0.00%), 5 'Buy' (55.56%), 4 'Hold' (44.44%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Revvity Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Nov 04, 2024 | Paul Knight | KeyBanc | $132.00 | $124.82 | 5.75% | 17.27% |
| Oct 15, 2024 | Luke Sergott | Barclays | $140.00 | $122.91 | 13.90% | 24.38% |
| Jul 30, 2024 | Derik de Bruin | Bank of America Securities | $127.00 | $125.59 | 1.12% | 12.83% |
| Jul 29, 2024 | Tycho Peterson | Jefferies | $125.00 | $125.29 | -0.23% | 11.05% |
| Jul 29, 2024 | Daniel Arias | Stifel Nicolaus | $110.00 | $120.16 | -8.46% | -2.27% |
| Jul 29, 2024 | Patrick Donnelly | Citigroup | $135.00 | $120.16 | 12.35% | 19.94% |
| Jul 29, 2024 | Vijay Kumar | Evercore ISI | $126.00 | $120.16 | 4.86% | 11.94% |
| Apr 29, 2024 | Dan Leonard | UBS | $120.00 | $105.02 | 14.26% | 6.61% |
The latest Revvity stock forecast, released on Nov 04, 2024 by Paul Knight from KeyBanc, set a price target of $132.00, which represents a 5.75% increase from the stock price at the time of the forecast ($124.82), and a 17.27% increase from RVTY last price ($112.56).
Revvity Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 2 | 8 |
| Avg Price Target | - | $136.00 | $126.88 |
| Last Closing Price | $112.56 | $112.56 | $112.56 |
| Upside/Downside | -100.00% | 20.82% | 12.72% |
In the current month, the average price target of Revvity stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Revvity's last price of $112.56. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Nov 04, 2024 | KeyBanc | Overweight | Overweight | Hold |
| Oct 15, 2024 | Barclays | Equal-Weight | Overweight | Upgrade |
| Aug 27, 2024 | Wells Fargo | Equal-Weight | Initialise | |
| Jul 30, 2024 | Cowen & Co. | Buy | Buy | Hold |
| Jul 30, 2024 | Barclays | Equal-Weight | Equal-Weight | Hold |
| Jul 30, 2024 | Bank of America Securities | Neutral | Neutral | Hold |
| Jul 29, 2024 | Jefferies | Hold | Hold | Hold |
| Jul 29, 2024 | Citigroup | Buy | Buy | Hold |
| Jul 29, 2024 | Evercore ISI | Outperform | Outperform | Hold |
| Apr 30, 2024 | Cowen & Co. | Buy | Buy | Hold |
| Apr 29, 2024 | UBS | Neutral | Neutral | Hold |
Revvity's last stock rating was published by KeyBanc on Nov 04, 2024. The company gave RVTY a "Overweight" rating, the same as its previous rate.
Revvity Financial Forecast
Revvity Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $674.87M | $741.21M | $711.80M | $1.23B | $1.26B | $1.36B | $1.17B | $1.23B | $1.31B | $1.35B | $964.02M | $811.72M | $652.40M | $805.50M | $706.92M |
| Avg Forecast | $827.01M | $764.39M | $773.58M | $720.90M | $773.98M | $721.27M | $725.99M | $680.40M | $731.15M | $679.66M | $690.33M | $647.25M | $677.13M | $695.40M | $708.38M | $678.90M | $1.03B | $1.02B | $1.20B | $1.19B | $1.27B | $1.04B | $1.12B | $1.21B | $1.23B | $840.15M | $722.01M | $649.26M | $801.08M | $721.38M |
| High Forecast | $838.04M | $774.59M | $783.90M | $730.52M | $784.30M | $730.89M | $735.68M | $690.11M | $733.30M | $679.73M | $690.33M | $647.45M | $682.85M | $706.09M | $717.83M | $687.96M | $1.04B | $1.02B | $1.20B | $1.19B | $1.27B | $1.04B | $1.12B | $1.21B | $1.23B | $840.15M | $722.01M | $649.26M | $801.08M | $721.38M |
| Low Forecast | $814.67M | $752.99M | $762.03M | $710.14M | $762.43M | $710.50M | $715.16M | $676.23M | $724.34M | $679.58M | $690.32M | $647.04M | $669.72M | $685.27M | $697.81M | $668.77M | $1.01B | $1.02B | $1.20B | $1.19B | $1.27B | $1.04B | $1.12B | $1.21B | $1.23B | $840.15M | $722.01M | $649.26M | $801.08M | $721.38M |
| # Analysts | 3 | 3 | 3 | 4 | 3 | 4 | 5 | 7 | 9 | 4 | 3 | 3 | 6 | 12 | 8 | 8 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 9 | 9 | 9 | 5 | 5 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.99% | 0.72% | 0.70% | 1.02% | 1.06% | 1.07% | 1.12% | 1.09% | 1.08% | 1.11% | 1.15% | 1.12% | 1.00% | 1.01% | 0.98% |
Revvity's average Quarter revenue forecast for Jun 23 based on 8 analysts is $708.38M, with a low forecast of $697.81M, and a high forecast of $717.83M. RVTY's average Quarter revenue forecast represents a 4.97% increase compared to the company's last Quarter revenue of $674.87M (Mar 23).
Revvity EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 4 | 3 | 4 | 5 | 7 | 9 | 4 | 3 | 3 | 6 | 12 | 8 | 8 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 9 | 9 | 9 | 5 | 5 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $158.42M | $266.62M | $220.69M | $380.02M | $391.55M | $465.46M | $313.89M | $414.87M | $551.24M | $546.42M | $312.35M | $236.86M | $114.97M | $170.25M | $147.27M |
| Avg Forecast | $251.75M | $232.69M | $235.48M | $219.45M | $235.61M | $219.56M | $221.00M | $207.12M | $222.57M | $206.89M | $210.14M | $197.03M | $206.13M | $211.68M | $215.64M | $206.66M | $313.19M | $305.05M | $359.56M | $355.16M | $380.39M | $310.97M | $335.36M | $361.69M | $365.93M | $250.95M | $215.67M | $193.94M | $239.28M | $215.48M |
| High Forecast | $255.11M | $235.79M | $238.62M | $222.38M | $238.75M | $222.49M | $223.95M | $210.07M | $223.22M | $206.92M | $210.14M | $197.09M | $207.86M | $214.94M | $218.51M | $209.42M | $317.37M | $305.05M | $359.56M | $355.16M | $380.39M | $310.97M | $335.36M | $361.69M | $365.93M | $250.95M | $215.67M | $193.94M | $239.28M | $215.48M |
| Low Forecast | $247.99M | $229.22M | $231.97M | $216.17M | $232.09M | $216.28M | $217.70M | $205.85M | $220.49M | $206.87M | $210.14M | $196.96M | $203.87M | $208.60M | $212.42M | $203.58M | $308.51M | $305.05M | $359.56M | $355.16M | $380.39M | $310.97M | $335.36M | $361.69M | $365.93M | $250.95M | $215.67M | $193.94M | $239.28M | $215.48M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.77% | 0.85% | 0.72% | 1.06% | 1.10% | 1.22% | 1.01% | 1.24% | 1.52% | 1.49% | 1.24% | 1.10% | 0.59% | 0.71% | 0.68% |
8 analysts predict RVTY's average Quarter EBITDA for Jun 23 to be $215.64M, with a high of $218.51M and a low of $212.42M. This is 36.12% upper than Revvity's previous annual EBITDA (Mar 23) of $158.42M.
Revvity Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 4 | 3 | 4 | 5 | 7 | 9 | 4 | 3 | 3 | 6 | 12 | 8 | 8 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 9 | 9 | 9 | 5 | 5 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $24.84M | $107.50M | $85.35M | $179.21M | $176.96M | $179.18M | $127.74M | $245.93M | $379.31M | $380.36M | $176.70M | $137.16M | $33.66M | $64.50M | $58.56M |
| Avg Forecast | $199.40M | $173.22M | $176.40M | $155.21M | $180.45M | $155.75M | $156.32M | $134.35M | $168.68M | $138.57M | $138.02M | $115.96M | $143.29M | $146.85M | $146.25M | $122.86M | $201.61M | $177.82M | $248.69M | $261.16M | $277.54M | $214.86M | $300.90M | $381.43M | $371.86M | $185.64M | $104.51M | $68.78M | $163.69M | $124.55M |
| High Forecast | $202.86M | $176.23M | $179.46M | $157.90M | $183.58M | $158.46M | $159.03M | $146.24M | $169.91M | $138.59M | $138.03M | $116.36M | $147.02M | $154.26M | $146.47M | $124.99M | $205.11M | $177.82M | $248.69M | $261.16M | $277.54M | $214.86M | $300.90M | $381.43M | $371.86M | $185.64M | $104.51M | $68.78M | $163.69M | $124.55M |
| Low Forecast | $195.53M | $169.86M | $172.98M | $152.20M | $176.95M | $152.73M | $153.29M | $129.59M | $163.76M | $138.55M | $138.01M | $115.55M | $142.04M | $141.92M | $146.04M | $120.48M | $197.70M | $177.82M | $248.69M | $261.16M | $277.54M | $214.86M | $300.90M | $381.43M | $371.86M | $185.64M | $104.51M | $68.78M | $163.69M | $124.55M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.20% | 0.53% | 0.48% | 0.72% | 0.68% | 0.65% | 0.59% | 0.82% | 0.99% | 1.02% | 0.95% | 1.31% | 0.49% | 0.39% | 0.47% |
Revvity's average Quarter net income forecast for Jun 23 is $146.25M, with a range of $146.04M to $146.47M. RVTY's average Quarter net income forecast represents a 488.67% increase compared to the company's last Quarter net income of $24.84M (Mar 23).
Revvity SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 4 | 3 | 4 | 5 | 7 | 9 | 4 | 3 | 3 | 6 | 12 | 8 | 8 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 9 | 9 | 9 | 5 | 5 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $248.56M | $244.32M | $239.97M | $330.02M | $334.39M | $355.25M | $339.05M | $281.82M | $251.41M | $263.05M | $225.25M | $221.03M | $208.57M | $210.74M | $204.17M |
| Avg Forecast | $239.68M | $221.53M | $224.19M | $208.92M | $224.31M | $209.03M | $210.40M | $197.19M | $211.89M | $196.97M | $200.06M | $187.58M | $196.24M | $201.53M | $205.30M | $196.75M | $298.17M | $268.86M | $316.90M | $313.02M | $335.26M | $274.08M | $295.57M | $318.77M | $322.52M | $221.18M | $190.08M | $170.93M | $210.89M | $189.91M |
| High Forecast | $242.87M | $224.48M | $227.18M | $211.71M | $227.30M | $211.82M | $213.21M | $200.00M | $212.52M | $196.99M | $200.06M | $187.64M | $197.90M | $204.63M | $208.03M | $199.38M | $302.15M | $268.86M | $316.90M | $313.02M | $335.26M | $274.08M | $295.57M | $318.77M | $322.52M | $221.18M | $190.08M | $170.93M | $210.89M | $189.91M |
| Low Forecast | $236.10M | $218.22M | $220.84M | $205.81M | $220.96M | $205.91M | $207.26M | $195.98M | $209.92M | $196.95M | $200.06M | $187.52M | $194.09M | $198.60M | $202.23M | $193.82M | $293.72M | $268.86M | $316.90M | $313.02M | $335.26M | $274.08M | $295.57M | $318.77M | $322.52M | $221.18M | $190.08M | $170.93M | $210.89M | $189.91M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.26% | 0.82% | 0.89% | 1.04% | 1.07% | 1.06% | 1.24% | 0.95% | 0.79% | 0.82% | 1.02% | 1.16% | 1.22% | 1.00% | 1.08% |
Revvity's average Quarter SG&A projection for Jun 23 is $205.30M, based on 8 Wall Street analysts, with a range of $202.23M to $208.03M. The forecast indicates a -17.40% fall compared to RVTY last annual SG&A of $248.56M (Mar 23).
Revvity EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 4 | 3 | 4 | 5 | 7 | 9 | 4 | 3 | 3 | 6 | 12 | 8 | 8 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 9 | 9 | 9 | 5 | 5 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.20 | $0.85 | $0.68 | $1.42 | $1.40 | $1.42 | $1.12 | $2.20 | $3.39 | $3.40 | $1.58 | $1.23 | $0.30 | $0.58 | $0.53 |
| Avg Forecast | $1.62 | $1.41 | $1.43 | $1.26 | $1.47 | $1.27 | $1.27 | $1.09 | $1.37 | $1.13 | $1.12 | $0.94 | $1.16 | $1.19 | $1.19 | $1.00 | $1.64 | $1.44 | $2.01 | $2.12 | $2.25 | $1.74 | $2.44 | $3.09 | $3.01 | $1.50 | $0.85 | $0.56 | $1.33 | $1.01 |
| High Forecast | $1.65 | $1.43 | $1.46 | $1.28 | $1.49 | $1.29 | $1.29 | $1.19 | $1.38 | $1.13 | $1.12 | $0.95 | $1.20 | $1.25 | $1.19 | $1.02 | $1.67 | $1.44 | $2.01 | $2.12 | $2.25 | $1.74 | $2.44 | $3.09 | $3.01 | $1.50 | $0.85 | $0.56 | $1.33 | $1.01 |
| Low Forecast | $1.59 | $1.38 | $1.41 | $1.24 | $1.44 | $1.24 | $1.25 | $1.05 | $1.33 | $1.13 | $1.12 | $0.94 | $1.15 | $1.15 | $1.19 | $0.98 | $1.61 | $1.44 | $2.01 | $2.12 | $2.25 | $1.74 | $2.44 | $3.09 | $3.01 | $1.50 | $0.85 | $0.56 | $1.33 | $1.01 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.20% | 0.52% | 0.47% | 0.71% | 0.66% | 0.63% | 0.64% | 0.90% | 1.10% | 1.13% | 1.05% | 1.45% | 0.54% | 0.44% | 0.53% |
According to 8 Wall Street analysts, Revvity's projected average Quarter EPS for Jun 23 is $1.19, with a low estimate of $1.19 and a high estimate of $1.19. This represents a 494.40% increase compared to RVTY previous annual EPS of $0.20 (Mar 23).
Revvity Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| ACRS | Aclaris Therapeutics | $3.26 | $6.00 | 84.05% | Buy |
| ICLR | ICON Public Limited Company | $203.26 | $337.00 | 65.80% | Buy |
| NEOG | Neogen | $12.13 | $17.50 | 44.27% | Buy |
| IQV | IQVIA | $196.64 | $252.80 | 28.56% | Buy |
| IDXX | IDEXX Laboratories | $427.09 | $510.00 | 19.41% | Buy |
| MTD | Mettler-Toledo | $1.25K | $1.41K | 13.28% | Hold |
| LH | Laboratory Corporation of America | $230.95 | $258.20 | 11.80% | Buy |
| RVTY | Revvity | $114.75 | $127.86 | 11.42% | Buy |
| CRL | Charles River Laboratories | $189.33 | $209.00 | 10.39% | Buy |
| A | Agilent | $136.46 | $147.40 | 8.02% | Buy |
| QGEN | Qiagen | $45.34 | $48.33 | 6.59% | Buy |
| MEDP | Medpace | $348.48 | $369.67 | 6.08% | Hold |
| WAT | Waters | $373.72 | $356.80 | -4.53% | Buy |
| TWST | Twist Bioscience | $48.40 | $46.00 | -4.96% | Buy |